Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 7 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 2 |
| Introduction | 11 | 3 |
| GBI Research Report Guidance | 11 | 1 |
| Disease Overview: Cardiovascular Diseases | 12 | 1 |
| Etiology of Cardiovascular Diseases | 12 | 1 |
| Coronary Heart Disease | 12 | 1 |
| Cerebrovascular Disease Stroke | 13 | 1 |
| Peripheral Vascular Disease | 13 | 1 |
| Valvular Heart Disease | 13 | 1 |
| Emerging Countries Cardiovascular Devices Market - Market Characterization | 14 | 15 |
| Emerging Countries Cardiovascular Devices Market, Revenue ($m), 2003 2010 | 14 | 1 |
| Emerging Countries Cardiovascular Devices Market, Revenue ($m), 2010 2017 | 15 | 1 |
| Emerging Countries Cardiovascular Devices Market, Key Company Shares (%), 2010 | 16 | 3 |
| Emerging Countries Cardiovascular Devices, Key Market Trends | 19 | 1 |
| Increasing Incidence of Cardiovascular Disease and Other Comorbid Conditions are Driving the Demand for Cardiovascular Devices in Emerging Countries | 19 | 1 |
| Multinational Companies Increasing Their Focus on Emerging Countries Such as India, China and Brazil | 20 | 1 |
| India is Emerging as a Destination for Cardiac Medical Tourism | 21 | 1 |
| Emerging Countries Cardiovascular Devices: Market Dynamics | 22 | 1 |
| Market Drivers | 22 | 1 |
| Health Care Reforms in China and Increased Healthcare Spending in India and China is Boosting the Growth of the Cardiovascular Device Market in Emerging Countries | 22 | 1 |
| Lifestyle Changes and Increased Risk Factors are Giving Rise to the Growing Prevalence of Cardiovascular Diseases in Emerging Countries | 23 | 3 |
| Population Aged Over 60 to Drive Growth in Cardiovascular Device Market in the Future | 26 | 1 |
| Rapidly Expanding Economy and Increasing Urbanization and Spending Power are Boosting Cardiovascular Disease Treatment | 27 | 1 |
| Increasing Adoption of Minimally Invasive Techniques Boosting Cardiovascular Procedure Volumes | 27 | 1 |
| Market Restraints | 27 | 1 |
| Inequity in Availability of Cardiovascular Treatment Options between Rural and Urban Areas Negatively Affecting the Cardiovascular Devices Market Growth | 27 | 1 |
| The Low Percentage of the Population with Healthcare Insurance in India and China is Slowing Procedure Volumes | 28 | 1 |
| Growth of Indigenous Cardiovascular Medical Device Companies in China Leading to Fragmented Market and Price Competition | 28 | 1 |
| Emerging Countries Cardiovascular Devices - Category Analysis | 29 | 70 |
| Cardiac Rhythm Management Devices | 29 | 1 |
| Emerging Countries Cardiac Rhythm Management Market, Revenue ($m) 2003 2010 | 30 | 1 |
| Emerging Countries Cardiac Rhythm Management Market, Revenue Forecasts ($m) 2010-2017 | 31 | 1 |
| Emerging Countries Cardiac Rhythm Management Market, Key Company Shares (%), 2010 | 32 | 3 |
| Emerging Countries Cardiac Rhythm Management: Market Dynamics | 35 | 1 |
| Market Drivers | 35 | 1 |
| Technological Innovations in Cardiac Rhythm Management (CRM) Driving the Market Ahead in Emerging Countries | 35 | 1 |
| Clinical Trial Outcomes to have a Positive Affect on the Cardiac Resynchronization Therapy Devices Market | 36 | 1 |
| New Technological Innovations Have Led to Increases in Average Selling Prices | 37 | 1 |
| Market Restraints | 37 | 1 |
| High Cost of Cardiac Rhythm Management Devices is a Growth Limiting Factor | 37 | 1 |
| Low Penetration in Emerging Markets Continues to Negatively Affect Overall Revenues | 37 | 1 |
| Lack of Adequate Physician Education and Training in Implanting Cardiac Rhythm Management Devices is Slowing Procedure Volumes | 38 | 1 |
| Emerging Countries External Defibrillator Market, Revenue ($m) 2003 2010 | 39 | 1 |
| Emerging Countries External Defibrillator Market, Revenue Forecasts ($m) 2010-2017 | 40 | 1 |
| Emerging Countries External Defibrillator Market, Key Company Shares (%), 2010 | 41 | 3 |
| Emerging Countries External Defibrillator: Market Dynamics | 44 | 1 |
| Market Drivers | 44 | 1 |
| Addition of Newer Hospitals and Rising Awareness about Basic Life Support is Increasing the Volumes of External Defibrillators. | 44 | 1 |
| Restraints | 45 | 1 |
| Significant Presence of Local Players in the Defibrillator Market Leading to Price Competition in Emerging Countries | 45 | 1 |
| Interventional Cardiology | 45 | 1 |
| Emerging Countries, Interventional Cardiology, Market Revenue ($m) 2003-2010 | 46 | 1 |
| Emerging Countries Interventional Cardiology Market Revenue Forecasts ($m) 2010 2017 | 47 | 1 |
| Emerging Countries, Interventional Cardiology Market, Key Company Shares (%), 2010 | 48 | 3 |
| Emerging Countries, Interventional Cardiology: Market Dynamics | 51 | 1 |
| Market Drivers | 51 | 1 |
| High incidence of Coronary Artery Disease (CAD) is Driving the Interventional Cardiology Market in the Emerging Countries | 51 | 1 |
| Drug Eluting Stents (DES) Continue to Drive the Interventional Cardiology Market Growth in Emerging Countries | 51 | 1 |
| Exponential Increase in Percutaneous Coronary Intervention and Catheterization Procedures Leading to Overall Market Growth in the Emerging Countries | 52 | 1 |
| Increasing Number of Catheterization Laboratories is Boosting the Procedure Volumes in India and China | 53 | 1 |
| Market Restraints | 53 | 1 |
| Lack of Infrastructure Facilities is Restraining Procedure Volumes | 53 | 1 |
| Alternative Treatment Options and Preference of Pharmacological Therapies is Minimizing the Need for PCI Procedures | 53 | 1 |
| Availability of Alternative Treatment Options is Slowing the Market Growth | 54 | 1 |
| Peripheral Vascular Devices | 54 | 1 |
| Emerging Countries, Peripheral Vascular Devices Market, Revenues ($m) 2003 2010 | 55 | 1 |
| Emerging Countries, Peripheral Vascular Devices Market, Revenue Forecasts ($m) 2010 2017 | 56 | 1 |
| Emerging Countries, Peripheral Vascular Devices Market, Key Company Shares (%), 2010 | 57 | 3 |
| Emerging Countries, Peripheral Vascular Devices: Market Dynamics | 60 | 1 |
| Market Drivers | 60 | 1 |
| High incidence of Diabetes (A Risk Factor for Peripheral Vascular Disease) in Emerging Countries Offers Huge Potential for the Peripheral Vascular Devices Market | 60 | 1 |
| Increased Focus on Emerging Markets by Major Companies Resulting in Improved Product Availability and Surgeon Skill Sets | 60 | 1 |
| Market Restraints | 60 | 1 |
| Inadequate Number of Highly Skilled Surgeons to Perform Complex Peripheral Vascular Surgeries Limiting the Growth of Procedure Volumes | 60 | 1 |
| Low Awareness and Diagnosis Rates of Deep Vein Thrombosis (DVT) in Emerging Countries is Having a Restraining Affect on the Peripheral Vascular Market | 61 | 1 |
| Cardiovascular Prosthetic Devices | 61 | 1 |
| Emerging Countries Cardiovascular Prosthetic Devices Market, Revenues ($m) 2003 2010 | 62 | 1 |
| Emerging Countries, Cardiovascular Prosthetic Devices Market, Revenue Forecasts ($m) 2010 2017 | 63 | 1 |
| Emerging Countries, Cardiovascular Prosthetic Devices Market, Key Company Shares (%), 2010 | 64 | 3 |
| Emerging Countries, Cardiovascular Prosthetic Devices: Market Dynamics | 67 | 1 |
| Market Drivers | 67 | 1 |
| Increased Adoption of Tissue Heart Valves in the Emerging Countries is Driving the Revenues of the Market | 67 | 1 |
| Prevalence of Rheumatic Fever in Emerging Countries is a Factor in the Use of Catheter Based Treatments for Valvular Heart Disease | 67 | 1 |
| Market Restraints | 68 | 1 |
| Lack of Robust Clinical Data Will Increase Diversity of Opinion Regarding Valvular Disease Management | 68 | 1 |
| Lower Adoption Rates and Constraints in Supply of Devices Adversely Affecting the Cardiovascular Prosthetic Device Market in Emerging Countries | 68 | 1 |
| Emerging Countries Cardiac Assist Devices Market, Revenues ($m) 2003 2010 | 69 | 1 |
| Emerging Countries, Cardiac Assist Devices Market, Revenue Forecasts ($m) 2010 2017 | 70 | 1 |
| Emerging Countries, Cardiac Assist Devices Market, Key Company Shares (%), 2010 | 71 | 3 |
| Emerging Countries, Cardiac Assist Devices: Market Dynamics | 74 | 1 |
| Market Drivers | 74 | 1 |
| Improvements in Cardiac Assist Devices Expected to Bolster Future Adoption Rates in Emerging Countries | 74 | 1 |
| Market Restraints | 74 | 1 |
| Lack of Effective Clinical Data and Complications Associated Proving Detrimental in the Adoption of Cardiac Assist Devices | 74 | 1 |
| Cardiovascular Surgery Devices | 75 | 1 |
| Emerging Countries, Cardiovascular Surgery Market, Revenue ($m) 2003 2010 | 76 | 1 |
| Emerging Countries, Cardiovascular Surgery Market, Revenue Forecasts ($m) 2010 2017 | 77 | 1 |
| Emerging Countries, Cardiovascular Surgery Market, Key Company Shares (%), 2010 | 78 | 3 |
| Emerging Countries, Cardiovascular Surgery: Market Dynamics | 81 | 1 |
| Market Drivers | 81 | 1 |
| On Pump Surgeries to Boost Market Revenues in the Emerging Countries | 81 | 1 |
| CABG the Only Choice in Case of Failed PCI Procedures and for Post Infarction Patients to Sustain the Market Growth | 81 | 1 |
| Market Restraints | 81 | 1 |
| Advances in Catheter Based Interventions and Increased Patient and Surgeon Preference for PCI have Stunted the Cardiovascular Surgery Devices Market Growth | 81 | 1 |
| Cardiovascular Surgery Requires a High Degree of Skill, Leading to Low Surgeon Preference | 81 | 1 |
| Electrophysiology | 82 | 1 |
| Emerging Countries, Electrophysiology Market, Revenue ($m) 2003 2010 | 83 | 1 |
| Emerging Countries, Electrophysiology Market, Revenue Forecast ($m) 2010-2017 | 84 | 1 |
| Emerging Countries, Electrophysiology Market, Key Company Shares (%), 2010 | 85 | 3 |
| Emerging Countries Electrophysiology: Market Dynamics | 88 | 1 |
| Market Drivers | 88 | 1 |
| Increasing Applications of Electrophysiology Having a Positive Impact on the Market | 88 | 1 |
| Growing Adoption Rates of Electrophysiology as a Treatment Modality to Drive the Market | 88 | 1 |
| Increase in Acceptance of Electrophysiology as a Treatment Option for Atrial Fibrillation is Expected to Increase Procedure Volumes | 88 | 1 |
| New Product Approvals and Technological Advances to Boost the Electrophysiology Market | 89 | 1 |
| Market Restraints | 89 | 1 |
| Lack of Awareness about Atrial Fibrillation (AF) and a Highly Under Penetrated Market is Leading to Under Diagnosis and Less Procedure Volume in the Emerging Countries | 89 | 1 |
| Huge Initial Set-Up Costs for Hospitals and Lack of Trained Electrophysiologists are Slowing Market Growth | 89 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices | 90 | 1 |
| Emerging Countries Cardiovascular Monitoring and Diagnostic Devices Market, Revenue ($m), 2003 2010 | 91 | 1 |
| Emerging Countries Cardiovascular Monitoring and Diagnostic Devices Market Revenue Forecasts ($m) 2010 2017 | 92 | 1 |
| Emerging Countries Cardiovascular Monitoring and Diagnostic Devices Market, Key Company Shares (%), 2010 | 93 | 3 |
| Emerging Countries Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics | 96 | 1 |
| Market Drivers | 96 | 1 |
| Greater Emphasis on the Concept of Preventive Care Medicine is Resulting in the Rise in Demand for Cardiovascular Monitoring and Diagnostic Devices | 96 | 1 |
| Rise in Adoption Rates of Technologically Advanced Cardiovascular Monitoring and Diagnostic Devices in the Emerging Countries Leading to Overall Growth of the Market | 96 | 1 |
| Exponential Rise in Number of Physician Offices in Emerging Countries is Leading to Increase in Volume Sales of ECG Monitoring Devices | 97 | 1 |
| Market Restraints | 98 | 1 |
| Presence of Many Local Players is Leading to Price War in the Cardiovascular Monitoring and Diagnostic Devices Market | 98 | 1 |
| Cost Cutting Measures by Hospitals in Emerging Countries is Leading to a Decrease in the Value of the Diagnostic and Monitoring Devices Market | 98 | 1 |
| Emerging Countries Cardiovascular Devices Market - Competitive Assessment | 99 | 4 |
| Emerging Countries Cardiovascular Devices Market - Key Market Participants | 103 | 12 |
| Boston Scientific Corporation | 103 | 1 |
| Business Overview | 103 | 1 |
| Key Marketed Products | 103 | 1 |
| Lepu Medical Technology (Beijing) Co.Ltd | 103 | 1 |
| Overview | 103 | 1 |
| Key Marketed Products | 103 | 1 |
| Medtronic, Inc | 104 | 1 |
| Business Overview | 104 | 1 |
| Key Marketed Products | 104 | 1 |
| Microport | 105 | 1 |
| Overview | 105 | 1 |
| Key Marketed Products | 105 | 1 |
| Terumo Corporation | 105 | 1 |
| Business Overview | 105 | 1 |
| Key Marketed Products | 105 | 1 |
| Abbott | 106 | 1 |
| Business Overview | 106 | 1 |
| Key Marketed Products | 106 | 1 |
| Biosensors International Group | 106 | 1 |
| Overview | 106 | 1 |
| Key Marketed Products | 106 | 1 |
| Cordis | 107 | 1 |
| Business Overview | 107 | 1 |
| Key Marketed Products | 107 | 1 |
| St. Jude Medical, Inc. | 107 | 1 |
| Business Overview | 107 | 1 |
| Key Marketed Products | 107 | 1 |
| Sorin Group | 108 | 1 |
| Business Overview | 108 | 1 |
| Key Marketed Products | 108 | 1 |
| ASAHI INTECC CO., LTD. (ASAHI) | 109 | 1 |
| Business Overview | 109 | 1 |
| Key Marketed Products | 109 | 1 |
| C.R. Bard, Inc. | 109 | 1 |
| Business Overview | 109 | 1 |
| Key Marketed Products | 109 | 1 |
| Vascular Concepts Limited | 109 | 1 |
| Business Overview | 109 | 1 |
| Key Marketed Products | 109 | 1 |
| Volcano Corporation | 110 | 1 |
| Business Overview | 110 | 1 |
| Key Marketed Products | 110 | 1 |
| Philips Healthcare | 110 | 1 |
| Business Overview | 110 | 1 |
| Key Marketed Products | 110 | 1 |
| Braile Biomedica | 110 | 1 |
| Business Overview | 110 | 1 |
| Key Marketed Products | 110 | 1 |
| Goodman Co., Ltd. | 111 | 1 |
| Business Overview | 111 | 1 |
| Key Marketed Products | 111 | 1 |
| MAQUET GmbH &Co. KG | 111 | 1 |
| Business Overview | 111 | 1 |
| Key Marketed Products | 111 | 1 |
| ZOLL Medical Corporation. | 111 | 1 |
| Business Overview | 111 | 1 |
| Key Marketed Products | 111 | 1 |
| Eurocor GmbH (Subsidary of Opto Circuits India Ltd | 112 | 1 |
| Business Overview | 112 | 1 |
| Key Marketed Products | 112 | 1 |
| Edwards Lifesciences Corporation | 112 | 1 |
| Business Overview | 112 | 1 |
| Key Marketed Products | 112 | 1 |
| Fukuda Denshi Co. Ltd | 112 | 1 |
| Overview | 112 | 1 |
| Key Marketed Products | 112 | 1 |
| Biosense Webster, Inc. | 113 | 1 |
| Business Overview | 113 | 1 |
| Key Marketed Products | 113 | 1 |
| BIOTRONIK SE &Co. KG | 113 | 1 |
| Business Overview | 113 | 1 |
| Key Marketed Products | 113 | 1 |
| Nihon Kohden | 114 | 1 |
| Overview | 114 | 1 |
| Key Marketed Products | 114 | 1 |
| Appendix | 115 | 6 |
| Definitions | 115 | 1 |
| Cardiovascular Devices | 115 | 1 |
| Cardiac Rhythm Management Devices | 115 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices | 115 | 1 |
| Cardiovascular Prosthetic Devices | 115 | 1 |
| Cardiovascular Surgery | 115 | 1 |
| Interventional Cardiology | 115 | 1 |
| Peripheral Vascular Devices | 115 | 1 |
| Electrophysiology | 115 | 1 |
| Acronyms | 116 | 2 |
| Research Methodology | 118 | 2 |
| Secondary Research | 118 | 1 |
| Primary Research | 118 | 1 |
| Models | 119 | 1 |
| Forecasts | 119 | 1 |
| Expert Panels | 119 | 1 |
| Contact Us | 119 | 1 |
| Disclaimer | 120 | 1 |
| Sources | 120 | 1 |